Shivin Pharma Scopia Limited - Due diligence report
A 360° intelligence report on Shivin Pharma Scopia Limited: trust score, financial health, credit view, compliance, directors, growth and di…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Shivin Pharma Scopia Limited — 360° Intelligence Report
Generated from MCA filings & public recordsShivin Pharma Scopia Limited is assessed as Caution Indicated with a Trust Score of 44/100. Shivin Pharma Scopia Limited is a public limited indian non-government company incorporated in 2016, operating in the Business Services sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.
Report generated on 25 Jul 2026 from the latest processed filings. Shivin Pharma Scopia Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 1 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is "Strike Off" - not Active.
- Last balance sheet is for Mar 2017 - filings overdue.
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VIVEKKUMAR CHAUDHARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AMITA BHARGAV BHATT | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BHARGAV KANTILAL BHATT | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- AMITA BHARGAV BHATT has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
As per FY 2017 annual returnPromoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 55Stakeholder Verdicts
Vendor · Banker · Investor- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management churn warrants questions.
MCA Filings & Events Timeline
Latest 6 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Shano Exports Private Limited | U74899DL1989PTC035328 | New Delhi, Delhi, India |
| Jain Agarwal Associates Private Limited | U74899DL1995PTC067960 | New Delhi, Delhi, India |
| San Innovative Systems Private Limited | U72900MH2008PTC179195 | Mumbai, Maharashtra, India |
| Averwith Exim Opc Private Limited | U51909DL2014OPC272682 | Delhi, Delhi, India |
| Gdf Suez Sales India Private Limited | U40106HR2013FTC055545 | Gurugram, Haryana, India |
| Fincurious | U74999KA2016PTC097098 | Bangalore, Karnataka, India |
| Hps Singh Ventures | U74999UP2016PTC088497 | Kanpur, Uttar Pradesh, India |
| Rewra Chemicals Private Limited | U24100BR2015PTC024402 | Nawada, Bihar, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Shivin Pharma Scopia Limited before audits and certifications: compliance score 30/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Shivin Pharma Scopia Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Enhanced diligence advised. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Shivin Pharma Scopia Limited - screening before a deeper diligence.
Vendor verdict: Caution indicated. Trust score 44/100, distress signals and MSME payment-delay disclosures - know whether Shivin Pharma Scopia Limited pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Shivin Pharma Scopia Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Shivin Pharma Scopia Limited an active company?
Shivin Pharma Scopia Limited has MCA status “Strike Off” with a compliance score of 30/100 (Caution Indicated).
Is Shivin Pharma Scopia Limited financially healthy?
Shivin Pharma Scopia Limited has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Shivin Pharma Scopia Limited?
Its overall Trust Score is 44/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Shivin Pharma Scopia Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Shivin Pharma Scopia Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Shivin Pharma Scopia Limited up to date with its ROC filings?
Last balance sheet is for Mar 2017 - filings overdue. Overall compliance score: 30/100 (Caution Indicated).
Is it risky to lend to Shivin Pharma Scopia Limited?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Enhanced diligence advised.